Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TZA reported for 2024 by RAS

2/7/25 TUZA

Yandex will organize festivals Comic Con and Igromir

2/7/25 YDEX

Cian launches receipt-for-share exchange

2/7/25 CIAN

T-Investments launched a venture capital fund

2/7/25 T

Yuzhuralzoloto decreased gold production by 17% in 2024

2/7/25 UGLD

Alrosa increases sales of investment diamonds

2/7/25 ALRS

Government tightens rules for circulation of precious metals and stones

2/7/25 MGKL

PIK bought a plot of land on Leningradskoye Shosse to build a business-class housing estate

2/7/25 PIKK

Renaissance Savings Non-Governmental Pension Fund was admitted to the guarantee system

2/7/25 RENI

Nefaz reported for 2024 by RAS

2/7/25 NFAZ